FRI, JAN 14, 2022 14:59 CET To continue Hamlet Pharma’s drug development process towards Phase III trials and future commercialization, it is essential to expand…
Read More
Hamlet Pharma is increasing its focus on the company’s digital channels, to provide easier access for shareholders and the public. So far, this effort includes…
Lund October 29, 2021 It is a great pleasure to announce that Hamlet Pharma has secured theproduction of larger quantities of Alpha1H, using a stable,…
We are proud to share the positive comments from the EIC Accelerator Horizon 2020 fund. The experienced EU evaluators state that: “All required milestones and…
Press Release, Lund July 6th, 2021 Following the successful human trial of the HAMLET drug candidate Alpha1H and publication of the results in Nature Communications,…
Press Release, Lund June 10th, 2021 The serendipitous discovery of HAMLET has provided novel insights into how to kill tumor cells without harming healthy tissues….
Press Release, Lund, June 7th, 2021 Hamlet and Tetra Pak wish to explore the possibilities to include into food products the active complex (The-A-complex) formed…
Press Release, Lund May 10, 2021 Hamlet Pharma is proud to announce the successful outcome of the dose-escalation study, which is an extension of the…
Press Release, Lund April 21, 2021 Hamlet Pharma is proud to announce that the report of the phase I/II bladder cancer trial has been accepted…
Press Release, Lund March 18, 2021 Today Hamlet Pharma is proud to announce new treatment advances in an experimental model of bladder cancer. A potent…